Filing Details

Accession Number:
0001104659-21-016743
Form Type:
13G Filing
Publication Date:
2021-02-09 17:00:42
Filed By:
Cooperatieve Aescap Venture I U.a.
Company:
Orphazyme A/s (NASDAQ:ORPH)
Filing Date:
2021-02-09
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Co peratieve Aescap Venture I U.A 0 1,758,105 0 1,758,105 1,758,105 5.1%
Aescap Venture Management B.V 0 1,758,105 0 1,758,105 1,758,105 5.1%
Patrick Johan Hendrik Krol 0 1,758,105 0 1,758,105 1,758,105 5.1%
Johan Gerhard Bosman 0 1,758,105 0 1,758,105 1,758,105 5.1%
Michiel Alexander de Haan 0 1,758,105 0 1,758,105 1,758,105 5.1%
Filing

 

 

 

  UNITED STATES  
  SECURITIES AND EXCHANGE COMMISSION  
  Washington, D.C. 20549  

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No.  )*

 

Orphazyme A/S

(Name of Issuer)

 

Ordinary Shares

(Title of Class of Securities)

 

687305102

(CUSIP Number)

 

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o Rule 13d-1(b)
o Rule 13d-1(c)
x Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 687305102
 
  1 Name of Reporting Persons
Coöperatieve Aescap Venture I U.A.
 
  2 Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
 
  3 SEC Use Only
 
  4 Citizenship or Place of Organization
The Netherlands
     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5 Sole Voting Power
0
 
6 Shared Voting Power
1,758,105
 
7 Sole Dispositive Power
0
 
8 Shared Dispositive Power
1,758,105
 
  9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,758,105
 
  10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11 Percent of Class Represented by Amount in Row (9)
5.1%
 
  12 Type of Reporting Person (See Instructions)
FI
           

(1) Based upon 34,697,763 ordinary shares outstanding as of October 1, 2020, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) October 2, 2020.

 

2

 

 

  1 Name of Reporting Persons
Aescap Venture Management B.V.
 
  2 Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
 
  3 SEC Use Only
 
  4 Citizenship or Place of Organization
The Netherlands
     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5 Sole Voting Power
0
 
6 Shared Voting Power
1,758,105
 
7 Sole Dispositive Power
0
 
8 Shared Dispositive Power
1,758,105
 
  9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,758,105
 
  10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11 Percent of Class Represented by Amount in Row (9)
5.1%
 
  12 Type of Reporting Person (See Instructions)
FI
           
 

(1) Based upon 34,697,763 ordinary shares outstanding as of October 1, 2020, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) October 2, 2020.

 

3

 

 

  1 Name of Reporting Persons
Patrick Johan Hendrik Krol
 
  2 Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
 
  3 SEC Use Only
 
  4 Citizenship or Place of Organization
The Netherlands
     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5 Sole Voting Power
0
 
6 Shared Voting Power
1,758,105
 
7 Sole Dispositive Power
0
 
8 Shared Dispositive Power
1,758,105
 
  9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,758,105
 
  10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11 Percent of Class Represented by Amount in Row (9)
5.1%
 
  12 Type of Reporting Person (See Instructions)
IN
           
 

(1) Based upon 34,697,763 ordinary shares outstanding as of October 1, 2020, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) October 2, 2020.

 

4

 

 

  1 Name of Reporting Persons
Johan Gerhard Bosman
 
  2 Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
 
  3 SEC Use Only
 
  4 Citizenship or Place of Organization
The Netherlands
     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5 Sole Voting Power
0
 
6 Shared Voting Power
1,758,105
 
7 Sole Dispositive Power
0
 
8 Shared Dispositive Power
1,758,105
 
  9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,758,105
 
  10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11 Percent of Class Represented by Amount in Row (9)
5.1%
 
  12 Type of Reporting Person (See Instructions)
IN
           
 

(1) Based upon 34,697,763 ordinary shares outstanding as of October 1, 2020, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) October 2, 2020.

 

5

 

 

  1 Name of Reporting Persons
Michiel Alexander de Haan
 
  2 Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
 
  3 SEC Use Only
 
  4 Citizenship or Place of Organization
The Netherlands
     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5 Sole Voting Power
0
 
6 Shared Voting Power
1,758,105
 
7 Sole Dispositive Power
0
 
8 Shared Dispositive Power
1,758,105
 
  9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,758,105
 
  10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11 Percent of Class Represented by Amount in Row (9)
5.1%
 
  12 Type of Reporting Person (See Instructions)
IN
           
 

(1) Based upon 34,697,763 ordinary shares outstanding as of October 1, 2020, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) October 2, 2020.

 

6

 

 

Item 1.
  (a). Name of Issuer
Orphazyme A/S (the “Issuer”)
  (b).

Address of Issuer’s Principal Executive Offices:
Ole Maaløes Vej 3, DK-2200

Copenhagen N

Denmark

 
Item 2(a). Name of Person Filing
Item 2(b). Address of Principal Business Office
Item 2(c).

Citizenship

 

(i) Coöperatieve Aescap Venture I U.A. (Fund”)
Barbara Strozzilaan 101
1083 HN Amsterdam
The Netherlands
Citizenship: The Netherlands

 

(ii) Aescap Venture Management B.V. (“Management”), as the manager of the Fund
Barbara Strozzilaan 101
1083 HN Amsterdam
The Netherlands
Citizenship: The Netherlands

 

(iii) Patrick Johan Hendrik Krol (“Krol”), as a managing director of Management
Barbara Strozzilaan 101
1083 HN Amsterdam
The Netherlands
Citizenship: The Netherlands

 

(iv) Johan Gerhard Bosman (“Bosman”), as a managing director of Management

Barbara Strozzilaan 101
1083 HN Amsterdam
The Netherlands
Citizenship: The Netherlands

 

(v) Michiel Alexander de Haan (“de Haan”), as a managing director of Management

Barbara Strozzilaan 101
1083 HN Amsterdam
The Netherlands
Citizenship: The Netherlands

 

The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”

Item 2(d). Title of Class of Securities:
Ordinary Shares (the “Shares”)
Item 2(e). CUSIP Number:
687305102
 
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
  This Item 3 is not applicable.

 

7

 

 

Item 4. Ownership.
  (a)

Amount beneficially owned:

As the manager of the Fund, any Shares held by the Fund may be deemed to be beneficially owned by Management. By virtue of their position as managers of Management, each of Krol, Bosman and de Haan may be deemed to beneficially own and have shared voting and dispositive power with respect to the Shares beneficially owned by Management

As of the date of this report, the Fund held an aggregate of 1,758,105 Shares.

  (b)

Percent of class:

The Fund may be deemed the beneficial owner of approximately 5.1% of the Shares outstanding.
Management may be deemed the beneficial owner of approximately 5.1% of the Shares outstanding.

Each of Krol, Bosman and de Haan may be deemed the beneficial owner of approximately 5.1% of the Shares outstanding.

  (c)

Number of shares as to which the Reporting person has:

Fund:

    (i)

Sole power to vote or to direct the vote:

0

    (ii)

Shared power to vote or to direct the vote:

1,758,105

    (iii)

Sole power to dispose or to direct the disposition of:

0

    (iv)

Shared power to dispose or to direct the disposition of:

1,758,105

    Management:
    (i)

Sole power to vote or to direct the vote:

0

    (ii)

Shared power to vote or to direct the vote:

1,758,105

    (iii)

Sole power to dispose or to direct the disposition of:

0

    (iv)

Shared power to dispose or to direct the disposition of:

1,758,105

    Krol:
    (i)

Sole power to vote or to direct the vote:

0

    (ii)

Shared power to vote or to direct the vote:

1,758,105

    (iii)

Sole power to dispose or to direct the disposition of:

0

    (iv)

Shared power to dispose or to direct the disposition of:

1,758,105

    Bosman:
    (i)

Sole power to vote or to direct the vote:

0

    (ii)

Shared power to vote or to direct the vote:

1,758,105

    (iii)

Sole power to dispose or to direct the disposition of:

0

    (iv)

Shared power to dispose or to direct the disposition of:

1,758,105

 

    de Haan:
    (i)

Sole power to vote or to direct the vote:

0

    (ii)

Shared power to vote or to direct the vote:

1,758,105

    (iii)

Sole power to dispose or to direct the disposition of:

0

    (iv)

Shared power to dispose or to direct the disposition of:

1,758,105

 

8

 

 

Item 5. Ownership of Five Percent or Less of a Class
   
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:    
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
   
This Item 6 is not applicable.
 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
   
This Item 7 is not applicable.
 
Item 8. Identification and Classification of Members of the Group.
   
This Item 8 is not applicable.
 
Item 9. Notice of Dissolution of Group.
   
This Item 9 is not applicable.

 

Item 10. Certification.
   
This Item 10 is not applicable.

 

9

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 9, 2021

 

  Coöperatieve Aescap Venture I U.A.
   
  By: /s/Patrick Krol | /s/Hans Bosman
    Name: Aescap Venture Management B.V.,
represented by Patrick Krol and Hans Bosman
    Title: Managing Directors

 

  Aescap Venture Management B.V.
   
  By: /s/Patrick Krol | /s/Hans Bosman
    Name: Patrick Krol and Hans Bosman
    Title: Managing Directors

 

 

  Patrick Johan Hendrik Krol
   
  By: /s/Patrick Johan Hendrik Krol

 

 

  Johan Gerhard Bosman
   
  By: /s/Johan Gerhard Bosman

 

 

  Michiel Alexander de Haan
   
  By: /s/Michiel Alexander de Haan

 

10